Benefit of trehalose preincubation prior to cryopreservation
DOI:
https://doi.org/10.13181/mji.v25i3.1595Keywords:
editorialAbstract
[no abstract available]
Downloads
References
Kusuma I, Hadi RS, Kiranadi B, Boediono A. Trehalose preincubation increases mesenchymal (CD271+) stem cells post cryopreservation viability. Med J Indones. 2016;25(3):129-35. http://dx.doi.org/10.13181/mji.v25i3.1273
Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JAW. Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology. 2015;71:181-97. http://dx.doi.org/10.1016/j.cryobiol.2015.07.003
Castillo N, García-Cadenas I, Barba P, Martino R, Azqueta C, Ferrà C, et al. Post-thaw viable CD45þ cells and clonogenic efficiency are associated with better engraftment and outcomes after single cord blood transplantation in adult patients with malignant diseases. Biol Blood Marrow Transplant. 2015;21:2167-72. http://dx.doi.org/10.1016/j.bbmt.2015.08.016
Francois M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-? licensing. Cytotherapy. 2012;14:147-52. http://dx.doi.org/10.3109/14653249.2011.623691
Moll G, Alm JJ, Davies LC, von Bahr L, Heldring N, Stenbeck-Funke L, et al. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells. 2014;32(9):2430-42. http://dx.doi.org/10.1002/stem.1729
Galipeau J. The mesenchymal stromal cell dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy. 2013;15(1):2-8. http://dx.doi.org/10.1016/j.jcyt.2012.10.002
Pollock K, Sumstad D, Kadidlo D, McKenna DH, Hubel A. Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. Cytotherapy. 2015;17:38-45. http://dx.doi.org/10.1016/j.jcyt.2014.06.008
Published
How to Cite
Issue
Section
License
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
